Africa Vaccine Acquisition TaskTeam Acquires 300 Million Sputnik V Vaccines from Russia

The Africa Vaccine Acquisition TaskTeam [AVATT], set up by the African Union to acquire additional vaccine doses so that Africa can attain a target immunization of 60% has announced that it has received an offer of 300 million Sputnik V vaccines from the Russian Federation. This includes a financing package for any member states wishing to secure this vaccine.

Meanwhile, AVATT advises that the 270 million doses previously secured from AstraZeneca, Pfizer, and Johnson & Johnson were all taken up by the first allocation phase deadline through the African Medical Supplies Platform (AMSP). With these additional 300 million Sputnik V vaccines, AMSP accelerates online COVID-19 vaccines pre-orders for the 55 African Union member states.

Dr. John Nkengasong, Director of the Africa Centres for Disease Control and Prevention (Africa CDC) said, “The Sputnik V vaccine from the Russian Federation is now available on the AMSP for the consideration of our AU Member States. Adding: “Bilateral and private sector partnerships such as these aids our efforts to bringing the COVID-19 pandemic to an end.”

While details, including clinical and technical information, are now accessible on the Africa Medical Supplies Platform (AMSP), Sputnik V vaccines will be available for 12 months commencing by May 2021. From today, the 55 African Union member states are all invited to visit www.amsp.africa and use their national access code – issued to all African Union member states’ Ministers of Finance and Health – to start the pre-order process.

African Union member states that wish to secure funding should approach the African Export-Import Bank (Afreximbank) through their Central Banks, as has been the case with the other vaccines that have been on offer. The Board of Afreximbank, last week, approved the USD$ 2 billion Advance Purchase Commitment for the participating suppliers, allowing the finalization of supply contracts.